Position in LQDA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$692,055
+$616,121 QoQ
Shares Held
8,680
+34.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#181
of 334 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 12%
Shared 88%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VIRTUS ADVISERS, LLC holds $9,867,527 across 13 Drug Manufacturers - Specialty & Generic names. LQDA ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
49,354 | $2,586,149 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
107,110 | $1,552,023 | |
| 3 | PAHC |
Phibro Animal Health Corp
|
43,092 | $1,353,088 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
14,294 | $1,183,257 | |
| 5 | LQDA |
Liquidia Corp
This page
|
8,680 | $692,055 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
36,823 | $637,406 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
2,714 | $457,417 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
315,737 | $359,940 |
All Filings in LQDA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $692,055 | 8,680 | Shares | Other | 2026-08-11 | |
| 2024-12-31 | $75,934 | 6,457 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $68,600 | 6,860 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $80,892 | 6,741 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $175,303 | 11,885 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $152,781 | 12,700 | Shares | Other | 2024-02-15 | |
| 2023-09-30 | $79,668 | 12,566 | Shares | Other | 2023-11-07 | |
| 2023-06-30 | $108,463 | 13,817 | Shares | Other | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||